Government on High Alert Amidst Resurgence of Mpox in Africa

The Health Ministry had issued a communicable disease alert, sensitized airport health teams, and conducted a video conference with state health authorities to strengthen surveillance and response capabilities. A network of 32 laboratories is equipped for testing, and protocols for prevention and treatment are being widely disseminated.

NMC Issues Advisory for Safe Work Environment in Medical Colleges

The advisory emphasizes the importance of developing comprehensive safety policies encompassing the entire campus, including OPDs, wards, casualty areas, hostels, and residential quarters. Adequate lighting, CCTV surveillance, and robust security measures are deemed essential for ensuring the safety of all staff members.

Report of the National Task Force on Mental Health and Well-being of Medical Students

The National Medical Commission (NMC) has published the Report of the National Task Force on Mental Health and Well-being of Medical Students. The report emphasizes that Medical colleges, as centers of learning and healthcare, have a crucial role to play in addressing mental health. The formation of the National Task Force on Mental Health and Well-being of Medical Students was a step towards prioritizing the mental health of future doctors.

ESIC’s Annual Health Check-Up for Individuals 40 and Older

The Employees’ State Insurance Corporation (ESIC) is offering an annual preventive health check-up for insured individuals and women aged 40 years and older. This initiative aims to promote the early detection and management of potential health issues.

Prohibition of Manufacture, Sale and Distribution Of S(+)Etodolac + Paracetamol

The Drugs Technical Advisory Board (DTAB) was tasked with examining the necessity of prohibition of the FDC. After careful deliberation and considering the scientific evidence, the DTAB concluded that the FDC lacked therapeutic justification and posed potential risks to human health. This finding was instrumental in the government’s decision to impose a complete ban on the drug.

Once Bitten And Twice Shy: India Battles Against Vector-Borne Diseases

The resurgence of dengue and malaria cases in India has ignited a pressing need for a comprehensive and coordinated approach to combat this vector-borne disease. The high-level inter-ministerial meeting convened by the Union Health Secretary underscored the gravity of the situation and the urgent steps required to prevent an outbreak of dengue. Additionally, the Ministry of Health & Family Welfare has also issued a press release on its measures for prevention of malaria.

CDSCO Imposes Limit on Cosmetic Product Applications

Effective from August 16, 2024, applicants can now submit a maximum of fifty products per application. By limiting the number of products per application, the CDSCO aims to streamline the application process and expedite the review and approval timelines.

Government Seeks Public Feedback on Drug Distribution Practices

The Central Drugs Standard Organisation (CDSCO) is seeking public feedback on draft guidelines for Good Distribution Practices (GDP) for pharmaceutical products. These guidelines aim to ensure proper storage and handling of medicines throughout the supply chain, from manufacturers to retailers.

India Makes Strides in Bulk Drug Manufacturing

The Production Linked Incentive (PLI) scheme for promoting domestic manufacturing of key starting materials (KSMs), drug intermediates, and active pharmaceutical ingredients (APIs) was launched in 2022. A press release on the progress of the scheme was issued on August 9, 2024.